GM-CSF [Leukine (Sargramostim)] ( DrugBank: Sargramostim )


1 disease
IDDisease name (Link within this page)Number of trials
229Autoimmune pulmonary alveolar proteinosis1

229. Autoimmune pulmonary alveolar proteinosis


Clinical trials : 43 Drugs : 34 - (DrugBank : 8) / Drug target genes : 3 - Drug target pathways : 14
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00901511
(ClinicalTrials.gov)
July 200911/5/2009Whole Lung Lavage (WLL)/Inhaled Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis (PAP)Whole Lung Lavage Followed by Inhaled Sargramostim in the Treatment of Autoimmune Pulmonary Alveolar ProteinosisPulmonary Alveolar ProteinosisDrug: GM-CSF [Leukine (Sargramostim)];Procedure: WLLIRCCS Policlinico S. MatteoAgenzia Italiana del FarmacoEnrolling by invitation18 YearsN/ABoth18Phase 2/Phase 3Italy